Physician profile
Elida Marquez
NPI 1700936358
$1,425.48
in general payments reported to CMS, 2019-2025
34 companies · $114 in 2025
The $114 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $308 · 2020: $108 · 2021: $206 · 2022: $239 · 2023: $220 · 2024: $230 · 2025: $114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $564.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $564.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $261.69 | 2019-2025 | |
| Pfizer INC. | $84.85 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $82.57 | 2022 | |
| Medtronic, INC. | $76.94 | 2024 | Ligasure, Venaseal |
| Roche Diagnostics Corporation | $73.08 | 2019-2020 | |
| Agile Therapeutics, INC. | $64.32 | 2023-2024 | Twirla |
| Therapeuticsmd, INC. | $62.18 | 2019-2022 | |
| Astellas Pharma US INC | $59.30 | 2024-2025 | Veozah |
| Shield Therapeutics INC | $58.22 | 2023-2024 | Accrufer |
| Daiichi Sankyo INC. | $54.67 | 2019-2021 | |
| Hologic Sales and Service, LLC | $52.50 | 2019-2023 | Coolseal Generator, Acessa Provu System |
| Aspira Women'S Health INC | $38.90 | 2022 | |
| Organon LLC | $36.91 | 2021-2024 | |
| Minerva Surgical, INC | $31.96 | 2025 | |
| Myovant Sciences INC. | $27.86 | 2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $27.53 | 2019-2021 | |
| Allergan, INC. | $26.99 | 2019 | |
| Axonics, INC. | $26.95 | 2021-2022 | |
| Ethicon US, LLC | $25.07 | 2024 | Ethicon, Stratafix |
| Conmed Corporation | $22.49 | 2023 | Airseal |
| Amag Pharmaceuticals, INC. | $20.85 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $20.03 | 2025 | |
| Myriad Women'S Health, INC. | $19.42 | 2023 | Myrisk |
| Lupin INC. | $18.89 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.57 | 2019 | |
| Ferring Pharmaceuticals INC. | $18.48 | 2019 | |
| Becton, Dickinson and Company | $17.83 | 2023 | Bd Onclarity |
| Coopersurgical, INC. | $15.55 | 2024 | Paragard T 380a |
| Boston Scientific Corporation | $14.88 | 2019 | |
| Davol INC. | $14.70 | 2022 | |
| Sumitomo Pharma America, INC. | $14.31 | 2024 | Myfembree |
| Evofem Biosciences, INC. | $14.21 | 2023 | Phexxi |
| Meditrina | $11.69 | 2024 | |
| Coloplast Corp | $11.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elida Marquez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.